RXO Inc: Truist Securities raises target price to $30 from $28
RXO•Truist Securities raised its target price for RXO Inc to $30 from $28.
Related News
Oppenheimer raises Marvell Technology target price to $425 from $325
MRVL•
Lakewood-Amedex announces positive preclinical data for bisphosphocin compounds
LABT•
WillScot elects Donald Slager to board, names him to audit and compensation committees
WSC•
Neogenomics, Inc.: BofA Global Research raises price objective to $20 from $16
NEO•
Jasper Therapeutics announces offer to purchase outstanding warrants
JSPR•